文献速递乳腺癌放疗放疗物理与技术

侧卧位等中心侧卧位全乳放疗的长期疗效与毒性

Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results.
PubMed 文献 · Radiother Oncol · 2017-07-19

该研究纳入2006至2010年832例早期乳腺癌保乳术后接受3D适形全乳放疗(ILD技术)的患者,中位随访6.4年。结果显示急性和晚期毒性低,无心脏或肺毒性报告,局部控制率和生存率良好,但需更长期随访确认。

要点

  • 1年时94.1%患者无皮肤毒性,无心脏或肺毒性报告。
  • 复发36例(3.6%),其中局部复发30例。

核心结论

  • 侧卧位全乳放疗在局部控制和生存方面效果优异,急性毒性谱良好,未观察到心脏或肺毒性。

研究设计与样本

  • 2006至2010年 Institut Curie 单中心纳入832例早期乳腺癌保乳术后接受3D适形全乳放疗(ILD技术)的女性患者。
  • 急性毒性每周评估,晚期毒性(6个月及以后)每6个月评估至放疗结束后5年,采用NCI CTC v3.0量表。
  • 进行剂量学研究分析平均心脏剂量及同侧和对侧肺平均剂量。

主要发现

  • 全部患者中94.1%在1年时无皮肤毒性,未报告心脏或肺毒性,中位总生存未达到。
  • 观察到36例(3.6%)复发:30例局部(乳腺)复发、4例淋巴结复发、2例同时出现局部和淋巴结复发。

关键数值与推荐

  • 分割方案:46.5%患者接受50Gy(全乳)+16Gy(瘤床补量)共33次;17.9%接受50Gy/25次;26.1%接受40Gy/15次或41.6Gy/13次;9.5%接受30Gy/5次。

临床怎么用

  • ILD全乳放疗可作为早期乳腺癌保乳术后放疗的可选技术,急性毒性可接受且无心脏肺毒性报告。
  • 罩杯大小和分割方式与急性皮炎相关,临床可据此优化患者选择和放疗计划。

局限性

  • 需要更长期随访以确认结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate previously published whole breast radiotherapy (WBRT) using ILD (isocentring lateral decubitus) technique in terms of toxicity and efficacy. MATERIALS AND METHODS: From 2006 to 2010, 832 female patients with early-stage breast cancer (BC) treated by conservative surgery underwent 3D-conformal WBRT-ILD at Institut Curie. The acute toxicity of treatment was evaluated weekly and the late toxicity (6months and later after the treatment) was evaluated every 6months till the 5th year after the end of the radiotherapy using NCI CTC v3.0 scale. Dosimetric study was performed to analyse the mean cardiac dose and the mean homolateral and contralateral lung doses. RESULTS: The median follow up was 6.4years. The median age was 61.5years (range, 29-90), and median body mass index (BMI) was 26.3. Fifty one percent of the patients presented left sided BC and 49% right sided. Different type of fractions were used: 46.5% of pts.: 50 (breast)+16Gy (boost) in 33fractions (fr), in 17.9%-50Gy/25fr, in 26.1%-40/15fr or 41.6Gy/13fr and in 9.5%: 30Gy/5fr. Acute dermatitis was present in 93% with a median of apparition of 4weeks, and only 2,8% grade 3. In multivariate analysis, the cup size had significant influence (p=0.0004) and the fractionation had a significative influence (p=0.0001). In the all patients' population, 94.1% of cases had no skin toxicity at 1year. No cardiac or pulmonary toxicity was reported. The median overall survival had not been reached at the end of follow-up. We observed 36 (3.6%) recurrences, as following: 30 local (breast) recurrences, 4 lymph node (LN), and 2pts experiencing both. CONCLUSION: Whole breast radiotherapy in the lateral decubitus position provides excellent results in terms of local control and survival. ILD is well tolerated with very good acute toxicity profile. No cardiac or pulmonary toxicity were observed in this study. Longer follow-up is needed to confirm these results.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Bronsart E, Dureau S, Xu HP, et al. Whole breast radiotherapy in the lateral isocentric lateral decubitus position: Long-term efficacy and toxicity results. Radiother Oncol. 2017. PMID: 28734546. doi:10.1016/j.radonc.2017.07.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。